These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15817132)
1. Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. Girgenrath M; Kostek CA; Miller JB BMC Neurol; 2005 Apr; 5(1):7. PubMed ID: 15817132 [TBL] [Abstract][Full Text] [Related]
2. Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice. Dominov JA; Kravetz AJ; Ardelt M; Kostek CA; Beermann ML; Miller JB Hum Mol Genet; 2005 Apr; 14(8):1029-40. PubMed ID: 15757977 [TBL] [Abstract][Full Text] [Related]
3. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals. Gawlik KI; Holmberg J; Durbeej M Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714 [TBL] [Abstract][Full Text] [Related]
4. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512 [TBL] [Abstract][Full Text] [Related]
5. A comparative freeze-fracture study of plasma membrane of dystrophic skeletal muscles in dy/dy mice with merosin (laminin 2) deficiency and mdx mice with dystrophin deficiency. Shibuya S; Wakayama Y; Oniki H; Kojima H; Saito M; Etou T; Nonaka I Neuropathol Appl Neurobiol; 1997 Apr; 23(2):123-31. PubMed ID: 9160897 [TBL] [Abstract][Full Text] [Related]
6. Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle. Wardrop KE; Dominov JA J Histochem Cytochem; 2011 Feb; 59(2):167-79. PubMed ID: 20876525 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869 [TBL] [Abstract][Full Text] [Related]
8. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Mueller GM; O'Day T; Watchko JF; Ontell M Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441 [TBL] [Abstract][Full Text] [Related]
9. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813 [TBL] [Abstract][Full Text] [Related]
10. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707 [TBL] [Abstract][Full Text] [Related]
11. Muscle satellite cell and atypical myogenic progenitor response following exercise. Parise G; McKinnell IW; Rudnicki MA Muscle Nerve; 2008 May; 37(5):611-9. PubMed ID: 18351585 [TBL] [Abstract][Full Text] [Related]
12. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980 [TBL] [Abstract][Full Text] [Related]
13. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Bertoni C; Rando TA Hum Gene Ther; 2002 Apr; 13(6):707-18. PubMed ID: 11936970 [TBL] [Abstract][Full Text] [Related]
14. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
18. The ontogeny of soleus muscles in mdx and wild type mice. Schäfer R; Zweyer M; Knauf U; Mundegar RR; Wernig A Neuromuscul Disord; 2005 Jan; 15(1):57-64. PubMed ID: 15639122 [TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610 [TBL] [Abstract][Full Text] [Related]
20. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins. Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]